These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 6602645

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Characterization of cholecystokinin binding sites in goldfish brain and pituitary.
    Himick BA, Vigna SR, Peter RE.
    Am J Physiol; 1996 Jul; 271(1 Pt 2):R137-43. PubMed ID: 8760214
    [Abstract] [Full Text] [Related]

  • 24. Distribution of immunoreactive thyrotropin-releasing hormone in the forebrain and hypophysis of the bullfrog, Rana catesbeiana.
    Seki T, Nakai Y, Shioda S, Mitsuma T, Kikuyama S.
    Cell Tissue Res; 1983 Jul; 233(3):507-16. PubMed ID: 6414710
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Cholecystokinin-like peptides in avian brain and gut.
    Dockray GJ.
    Experientia; 1979 May 15; 35(5):628-30. PubMed ID: 446660
    [Abstract] [Full Text] [Related]

  • 28. The subcellular distribution of peptides immunoreactive for the carboxyl-terminal extension of cholecystokinin in rat brain.
    Allard LR, Beinfeld MC.
    Neuropeptides; 1985 Jun 15; 6(3):239-45. PubMed ID: 4022279
    [Abstract] [Full Text] [Related]

  • 29. Measurement of tissue cholecystokinin (CCK) concentrations by bioassay and specific radioimmunoassay: characterization of the bioactivity of CCK-58 before and after tryptic cleavage.
    Höcker M, Schmidt WE, Wilms HM, Lehnhoff F, Nustede R, Schafmayer A, Fölsch UR.
    Eur J Clin Invest; 1990 Oct 15; 20 Suppl 1():S45-50. PubMed ID: 2124997
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Anatomical distribution of a CCK-oktapeptide like substance in the human brain (author's transl)].
    Müller JE, Wolharn R, Hengels KJ, Scholten T, Fritsch WP, Huth F.
    Z Gastroenterol; 1979 Mar 15; 17(3):146-53. PubMed ID: 433367
    [Abstract] [Full Text] [Related]

  • 35. In vivo studies on the basal and evoked release of cholecystokinin and vasoactive intestinal polypeptide from cat cerebral cortex and periventricular structures.
    Wang JY, Yaksh TL, Go VL.
    Brain Res; 1983 Nov 28; 280(1):105-17. PubMed ID: 6652473
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Measurement and characterisation of human cholecystokinin-like immunoreactivity (CCK-LI) in tissues by radioimmunoassay.
    Bacarese-Hamilton AJ, Adrian TE, Bloom SR.
    Clin Chim Acta; 1984 Dec 29; 144(2-3):213-24. PubMed ID: 6529856
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Identification and localization of glucagon-like peptide-1 and its receptor in rat brain.
    Shimizu I, Hirota M, Ohboshi C, Shima K.
    Endocrinology; 1987 Sep 29; 121(3):1076-82. PubMed ID: 3040376
    [Abstract] [Full Text] [Related]

  • 40. Regional differences in the development of cholecystokinin-like activity in rat brain.
    Varró A, Bu'lock AJ, Williams RG, Dockray GJ.
    Brain Res; 1983 Sep 29; 285(3):347-52. PubMed ID: 6313134
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.